These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32048534)

  • 1. Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer.
    Kong L; Liu P; Zheng M; Xue B; Liang K; Tan X
    Epigenomics; 2020 Mar; 12(6):507-524. PubMed ID: 32048534
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma.
    Xu Y; She Y; Li Y; Li H; Jia Z; Jiang G; Liang L; Duan L
    Biomed Pharmacother; 2020 May; 125():109859. PubMed ID: 32036209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
    Song Y; Yang K; Sun T; Tang R
    BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma.
    Zheng M; Hu Y; Gou R; Wang J; Nie X; Li X; Liu Q; Liu J; Lin B
    Aging (Albany NY); 2019 Jun; 11(12):4198-4215. PubMed ID: 31257224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
    Zhao Y; Gao Y; Xu X; Zhou J; Wang H
    BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of genomic, epigenomic and transcriptomic data identified molecular subtypes of esophageal carcinoma.
    Ma M; Chen Y; Chong X; Jiang F; Gao J; Shen L; Zhang C
    Aging (Albany NY); 2021 Feb; 13(5):6999-7019. PubMed ID: 33638948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative analysis of genomic and epigenetic regulation of endometrial cancer.
    Zhong Q; Fan J; Chu H; Pang M; Li J; Fan Y; Liu P; Wu C; Qiao J; Li R; Hang J
    Aging (Albany NY); 2020 May; 12(10):9260-9274. PubMed ID: 32412912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
    Liu N; Wu Y; Cheng W; Wu Y; Wang L; Zhuang L
    BMC Cancer; 2021 Apr; 21(1):460. PubMed ID: 33902514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma.
    Chen W; Cheng P; Jiang J; Ren Y; Wu D; Xue D
    Aging (Albany NY); 2020 Jul; 12(13):12703-12725. PubMed ID: 32639949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive data analysis of genomics, epigenomics, and transcriptomics to identify specific biomolecular markers for prostate adenocarcinoma.
    Ye C; Wang H; Li Z; Xia C; Yuan S; Yan R; Yang X; Ma T; Wen X; Yang D
    Transl Androl Urol; 2021 Jul; 10(7):3030-3045. PubMed ID: 34430406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-omics data simulator for complex disease studies and its application to evaluate multi-omics data analysis methods for disease classification.
    Chung RH; Kang CY
    Gigascience; 2019 May; 8(5):. PubMed ID: 31029063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics analysis to identify driving factors in colorectal cancer.
    Xu X; Gong C; Wang Y; Hu Y; Liu H; Fang Z
    Epigenomics; 2020 Sep; 12(18):1633-1650. PubMed ID: 32573269
    [No Abstract]   [Full Text] [Related]  

  • 13. Multi-Omics Integrative Analysis Uncovers Molecular Subtypes and mRNAs as Therapeutic Targets for Liver Cancer.
    Shen Y; Xiong W; Gu Q; Zhang Q; Yue J; Liu C; Wang D
    Front Med (Lausanne); 2021; 8():654635. PubMed ID: 34109194
    [No Abstract]   [Full Text] [Related]  

  • 14. Development and validation of the trans-omics model for pancreatic adenocarcinoma.
    Huang W; Weng W; Wu B; Ye T; Lin Z; Zhang Z; Shi K
    Epigenomics; 2021 Jan; 13(1):15-30. PubMed ID: 33356543
    [No Abstract]   [Full Text] [Related]  

  • 15. Estimating gene expression from DNA methylation and copy number variation: A deep learning regression model for multi-omics integration.
    Seal DB; Das V; Goswami S; De RK
    Genomics; 2020 Jul; 112(4):2833-2841. PubMed ID: 32234433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis.
    Jia Y; Shen M; Zhou Y; Liu H
    Acta Biochim Pol; 2020 Dec; 67(4):501-508. PubMed ID: 33253517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated multi-omics analysis of ovarian cancer using variational autoencoders.
    Hira MT; Razzaque MA; Angione C; Scrivens J; Sawan S; Sarker M
    Sci Rep; 2021 Mar; 11(1):6265. PubMed ID: 33737557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
    Kim D; Li R; Dudek SM; Ritchie MD
    J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodeficiency in Pancreatic Adenocarcinoma with Diabetes Revealed by Comparative Genomics.
    Yan Y; Gao R; Trinh TLP; Grant MB
    Clin Cancer Res; 2017 Oct; 23(20):6363-6373. PubMed ID: 28684632
    [No Abstract]   [Full Text] [Related]  

  • 20. Framework for the Integration of Genomics, Epigenomics and Transcriptomics in Complex Diseases.
    Pineda S; Gomez-Rubio P; Picornell A; Bessonov K; Márquez M; Kogevinas M; Real FX; Van Steen K; Malats N
    Hum Hered; 2015; 79(3-4):124-36. PubMed ID: 26201698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.